financetom
Business
financetom
/
Business
/
Insight Enterprises Shares Fall After Lower Q1 Adjusted Earnings, Net Sales
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Insight Enterprises Shares Fall After Lower Q1 Adjusted Earnings, Net Sales
May 25, 2025 11:22 PM

09:54 AM EDT, 05/01/2025 (MT Newswires) -- Insight Enterprises ( NSIT ) shares fell 5.3% in recent Thursday trading after the company reported Q1 adjusted earnings of $2.06 per diluted share, down from $2.37 a year earlier.

Four analysts polled by FactSet expected $2.01.

Net sales for the quarter ended March 31 were $2.1 billion, down from $2.38 billion a year earlier.

Four analysts surveyed by FactSet expected $2.19 billion.

The company maintained its 2025 adjusted diluted EPS outlook of $9.70 to $10.10. Analysts surveyed by FactSet expect $9.82.

Price: 130.99, Change: -7.29, Percent Change: -5.27

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TriMas Q1 Earnings, Revenue Rise; Reaffirms Guidance
TriMas Q1 Earnings, Revenue Rise; Reaffirms Guidance
May 25, 2025
10:18 AM EDT, 04/29/2025 (MT Newswires) -- TriMas ( TRS ) reported Q1 adjusted earnings Tuesday of $0.46 per diluted share, up from $0.37 a year earlier. Two analysts polled by FactSet expected $0.40. Revenue for the quarter ended March 31 was $241.7 million, up from $227.1 million a year earlier. Two analysts surveyed by FactSet expected $235.4 million. The...
AstraZeneca Q1 Earnings Rise, But China Drug Allegations May Lead To $8 Million Penalty
AstraZeneca Q1 Earnings Rise, But China Drug Allegations May Lead To $8 Million Penalty
May 25, 2025
AstraZeneca Plc ( AZN ) on Tuesday reported first-quarter 2025 sales of $13.59 billion, up 7% year over year (+10% at constant currency), slightly missing the consensus of $13.71 billion, driven by double-digit growth in oncology and biopharmaceuticals. The company’s adjusted EPADS reached $1.25, beating the consensus of $1.11. The adjusted EPS was $2.09 (1 ADR = 2 Common Shares). AstraZeneca’s top business, oncology, increased 10%...
Alibaba Debuts Qwen3 Hybrid Reasoning Models
Alibaba Debuts Qwen3 Hybrid Reasoning Models
May 25, 2025
10:16 AM EDT, 04/29/2025 (MT Newswires) -- Alibaba Group ( BABA ) introduced Tuesday the Qwen3 upgrade for its artificial intelligence model featuring hybrid reasoning capabilities. According to Alibaba ( BABA ), hybrid reasoning models combine traditional large language model capabilities with advanced, dynamic reasoning. The new Qwen3 models can switch between non-thinking mode for general purpose responses and thinking...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved